Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000908834-22-000076
Filing Date
2022-02-10
Accepted
2022-02-10 16:44:30
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT #1 13ga1_lombardusa.htm SC 13G/A 36333
  Complete submission text file 0000908834-22-000076.txt   37775
Mailing Address 72 HAMMERSMITH ROAD LONDON X0 W14 8TH
Business Address 72 HAMMERSMITH ROAD LONDON X0 W14 8TH 44-0-20-3457 6900
Silence Therapeutics plc (Subject) CIK: 0001479615 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0
Type: SC 13G/A | Act: 34 | File No.: 005-92205 | Film No.: 22614748
SIC: 2834 Pharmaceutical Preparations

Mailing Address 452 FIFTH AVENUE, 25TH FLOOR NEW YORK NY 10018
Business Address 452 FIFTH AVENUE, 25TH FLOOR NEW YORK NY 10018 212-295-6200
Lombard Odier Asset Management (USA) Corp (Filed by) CIK: 0001491719 (see all company filings)

EIN.: 061603711 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A